Defective natural killer (NK) cell‐mediated cytotoxicity does not imply clonal involvement of NK cells in myelodysplastic syndromes
- 1 June 1994
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 87 (2) , 396-398
- https://doi.org/10.1111/j.1365-2141.1994.tb04928.x
Abstract
SUMMARY. The clonality of purified cells was examined in 10 myelodysplastic syndromes (MDS) patients by analysing the restriction fragment length polymorphism and methylation pattern of the phosphoglycerate‐kinase gene. Natural killer (NK) cell‐mediated cytotoxicity was also examined. The granulocytes and monocytes were monoclonal or oligoclonal in all cases, except for the monocytes in one case. Conversely, the NK and T cells had a polyclonal pattern in most cases, including all cases who had defective NK cellmediated cytotoxicty. The hypothesis that reduced NK cellmediated cytotoxicity in MDS is caused by a clonal involvement of NK cells was not supported by the present study.Keywords
This publication has 7 references indexed in Scilit:
- Assessment of therapeutic potential of interleukin 2 for myelodysplastic syndromesBritish Journal of Haematology, 1994
- Relapsed myelodysplastic clone differs from acute onset clone as shown by X-linked DNA polymorphism patterns in a patient with acute myeloid leukemia [see comments]Blood, 1993
- The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow cultureBlood, 1992
- Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase geneBlood, 1992
- Studies on clonality by PCR analysis of the PGK-1 geneNucleic Acids Research, 1991
- Biology and clinical relevance of human natural killer cellsBlood, 1990
- What are killer cells and what do they do?Blood Reviews, 1988